Abstract
As cosmetic technology advances, there is an increasing need to use new active ingredients in the development of cosmetic products. In the last few years application of fullerene C60 and its derivates in cosmetics has been intensively tested. Fullerenes display a wide range of biological activities. Potent scavenging capacities against radical oxygen species (ROS) and excellent potential as biological antioxidants made fullerenes suitable active compounds in the preparation of skin rejuvenation cosmetic formulations. Currently published evidence on biological activities of fullerenes relevant for their cosmetic use and examples of published patents to illustrate application of fullerenes in cosmetic technology are presented. Future trends in the development of cosmetic formulations including fullerenes are discussed.
Keywords: Fullerene, cosmetic, biological application
Recent Patents on Biotechnology
Title: Use of Fullerenes in Cosmetics
Volume: 3 Issue: 2
Author(s): Marko Lens
Affiliation:
Keywords: Fullerene, cosmetic, biological application
Abstract: As cosmetic technology advances, there is an increasing need to use new active ingredients in the development of cosmetic products. In the last few years application of fullerene C60 and its derivates in cosmetics has been intensively tested. Fullerenes display a wide range of biological activities. Potent scavenging capacities against radical oxygen species (ROS) and excellent potential as biological antioxidants made fullerenes suitable active compounds in the preparation of skin rejuvenation cosmetic formulations. Currently published evidence on biological activities of fullerenes relevant for their cosmetic use and examples of published patents to illustrate application of fullerenes in cosmetic technology are presented. Future trends in the development of cosmetic formulations including fullerenes are discussed.
Export Options
About this article
Cite this article as:
Lens Marko, Use of Fullerenes in Cosmetics, Recent Patents on Biotechnology 2009; 3 (2) . https://dx.doi.org/10.2174/187220809788700166
DOI https://dx.doi.org/10.2174/187220809788700166 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Bio-Drugs as Matrix Metalloproteinase Inhibitors: New Perspectives on the Horizon?
Recent Patents on Anti-Cancer Drug Discovery Expanding the Biotherapeutics Realm via miR-34a: “Potent Clever Little” Agent in Breast Cancer Therapy
Current Pharmaceutical Biotechnology Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioinformatic Application in Proteomic Research on Biomarker Discovery and Drug Target Validation
Current Bioinformatics Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science The Role of DNA-Microarray in Translational Cancer Research
Current Pharmacogenomics Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome
Current Pharmaceutical Design Luminescent Silica Nanoparticles for Cancer Diagnosis
Current Medicinal Chemistry Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma
Anti-Cancer Agents in Medicinal Chemistry PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets Metabolism of Acrylamide: Interindividual and Interspecies Differences as Well as the Application as Biomarkers
Current Drug Metabolism Anticancer Activity and Anti-inflammatory Studies of 5-Aryl-1,4-benzodiazepine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism The Hedgehog Knows Many Tricks
Current Drug Targets